MBS635958 | Bacillus anthracis Lethal Factor Protease Inhibitor-1 (LFPI), Recombinant (Anthrax)

Bacillus anthracis Lethal Factor Protease Inhibitor-1 (LFPI), Recombinant (Anthrax) | MBS635958 | MyBiosource

Product Short Name: [Bacillus anthracis Lethal Factor Protease Inhibitor-1]

Product Name Synonyme: N/A

Other Names: N/A

Product Gene Name: N/A

Product Gene Name Synonyme: N/A

Other Gene Names: N/A

Clonality: N/A

Isotype: N/A

Clone: N/A

Host: N/A

Reactivity: N/A

Specificity: LFPI-4 is a cell-permeable N-acetylated, C-hydroxamate derivative of a 14-mer peptide designed from the MEK-2 template that acts as a competitive inhibitor of Anthrax lethal factor (LF) metalloprotease (Ki = 1 nM). Also inhibits MEK-3 cleavage. Protects against Anthrax toxin induced cytotoxicity in RAW264.7 and J772.A1 cells..

Purity: Highly Purified
97% by HPLC.

Form: Supplied as a trifluoroacetate salt.Solubility: DMSO

Concentration: N/A

Storage Stability: Lyophilized powder may be stored at 4 degree C for short-term only. Stable for 12 months at -20 degree C. Reconstitute to nominal volume (see reconstitution instructions for peptides) and store at -20 degree C. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Further dilutions can be made in assay buffer.

Tested Application: N/A